Related references
Note: Only part of the references are listed.Interim analysis of the Spanish Lung Cancer Group (SLCG) BRCA1-RAP80 Expression Customization (BREC) randomized phase III trial of customized therapy in advanced non-small cell lung cancer (NSCLC) patients (p) (NCT00617656/GECP-BREC).
Teresa Moran et al.
JOURNAL OF CLINICAL ONCOLOGY (2017)
Two biomarker-directed randomized trials in European and Chinese patients with nonsmall-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studiesaEuro
T. Moran et al.
ANNALS OF ONCOLOGY (2014)
The predictive value of BRCA1 and RAP80 mRNA expression in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy
B. Zheng et al.
ANNALS OF ONCOLOGY (2013)
Randomized International Phase III Trial of ERCC1 and RRM1 Expression-Based Chemotherapy Versus Gemcitabine/Carboplatin in Advanced Non-Small-Cell Lung Cancer
Gerold Bepler et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
The predictive value of 53BP1 and BRCA1 mRNA expression in advanced non-small-cell lung cancer patients treated with first-line platinum-based chemotherapy
Laura Bonanno et al.
ONCOTARGET (2013)
HERC2 Is an E3 Ligase That Targets BRCA1 for Degradation
Wenwen Wu et al.
CANCER RESEARCH (2010)
HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors on damaged chromosomes
Simon Bekker-Jensen et al.
NATURE CELL BIOLOGY (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Customized Treatment in Non-Small-Cell Lung Cancer Based on EGFR Mutations and BRCA1 mRNA Expression
Rafael Rosell et al.
PLOS ONE (2009)
Platinum resistance: The role of DNA repair pathways
Lainie P. Martin et al.
CLINICAL CANCER RESEARCH (2008)
The DNA damage response: Ten years after
J. Wade Harper et al.
MOLECULAR CELL (2007)
Orchestration of the DNA-damage response by the RNF8 ubiquitin ligase
Nadine K. Kolas et al.
SCIENCE (2007)
RNF8 transduces the DNA-damage signal via histone ubiquitylation and checkpoint protein assembly
Michael S. Y. Huen et al.
CELL (2007)
RNF8 ubiquitylates histones at DNA double-strand breaks and promotes assembly of repair proteins
Niels Mailand et al.
CELL (2007)
The ubiquitin-interacting motif-containing protein RAP80 interacts with BRCA1 and functions in DNA damage repair response
Jun Yan et al.
CANCER RESEARCH (2007)
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
M Taron et al.
HUMAN MOLECULAR GENETICS (2004)
Binding and recognition in the assembly of an active BRCA1 /BARD1 ubiquitin-ligase complex
PS Brzovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
BRCA1:: mechanisms of inactivation and implications for management of patients
RD Kennedy et al.
LANCET (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development
V Joukov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
The breast cancer susceptibility gene BRCA1 is required for subnuclear assembly of Rad51 and survival following treatment with the DNA cross-linking agent cisplatin
A Bhattacharyya et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
